Endocrine Control of Growth

Human Growth and Development

Volumn , Issue , 2012, Pages 109-121

  Rosenfeld, Ron G ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882843810     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-383882-7.00005-2     Document Type: Chapter

References (35)

1. R.G. Rosenfeld (2004) Gender differences in height: an evolutionary perspective. J Pediatr Endocrinol Metab 17(Suppl. 4), 1267-1271.
2. B. Bogin (2001) The growth of humanity. New York: Wiley-Liss
3. R.G. Rosenfeld and P. Cohen (2008) Disorders of growth hormone/insulin-like growth factor secretion and action. M.A. Sperling (Ed.) Pediatric endocrinology 3rd ed. Philadelphia, PA: Saunders 254-334.
4. W.D. Salmon Jr. and W.H. Daughaday (1957) A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49 825-836.
5. W.D. Salmon Jr. and M.R. DuVall (1970) A serum fraction with sulfation factor activity stimulates in vitro incorporation of leucine and sulfate into protein–polysaccharide complexes, uridine into RNA, and thymidine into DNA of costal cartilage from hypophysectomized rats. Endocrinology 86 721-727.
6. W.H. Daughaday, K. Hall, M.S. Raben, J.D. Salmon, L. Van Den Brande and J.J. Van Wyk (1972) Somatomedin: proposed designation for sulphation factor. Nature 235 107.
7. W. Rinderknecht and R.E. Humbel (1976) Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: evidence for structural homology with insulin B chain. Proc Natl Acad Sci USA 73 4379-4381.
8. G.B. Udy, R.P. Towers, R.G. Snell, R.J. Wilkins, S.-H. Park, P.A. Ram, et al. (1997) Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 94 7239-7244.
9. M.A. Derr, P. Fang, S.K. Sinha, S. Ten, V. Hwa and R.G. Rosenfeld (2011) A novel Y332C missense mutation in the intracellular domain of the human growth hormone receptor (GHR) does not alter STAT5b signaling: redundancy of GHR intracellular tyrosines involved in STAT5b signaling. Horm Res Pediatr 75 187-199.
10. M.A. Derr, J. Aisenberg, P. Fang, Y. Tenenbaum-Rahover, R.G. Rosenfeld and V. Hwa (2011) The growth hormone receptor (GHR) c899dupC mutation functions as a dominant negative: insights into the pathophysiology of intracellular GHR defects. J Clin Endocrinol Metab 96 E1896-E1904.
11. E.M. Kofoed, V. Hwa, B. Little, K.A. Woods, C.K. Buckway, J. Tsubaki, et al. (2003) Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 349 1139-1147.
12. R.G. Rosenfeld, A. Belgorosky, C. Camacho-Hubner, M.O. Savage, J.M. Wit and V. Hwa (2007) Defects in growth hormone receptor signaling. Trends Endocrinol Metab 18 134-141.
13. J. Woelfle, D.J. Chia and P. Rotwein (2003) Mechanisms of growth hormone (GH) action. Identification of conserved STAT5 binding sites that mediate GH-induced insulin-like growth factor-1 gene activation. J Biol Chem 278 51261-51266.
14. F. Lupu, J.D. Terwilliger, L. Kaechoong, G.V. Segre and A. Efstratiadis (2001) Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229 141-162.
15. C.L. Vnencak-Jones, J.A. Phillips III, E.Y. Chen and P.H. Seeburg (1988) Molecular basis of human growth hormone gene deletions. Proc Natl Acad Sci USA 85 5615-5619.
16. R.G. Rosenfeld, A.L. Rosenbloom and J. Guevara-Aguirre (1994) Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 15 369-390.
17. K.A. Woods, C. Camacho-Hubner, M.O. Savage and A.J. Clark (1996) Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335 1363-1367.
18. M.J. Walenkamp, M. Karperien, A.M. Pereira, Y. Hilhorst-Hofstee, J. van Doorn, J.W. Chen, et al. (2005) Homozygous and heterozygous expression of a novel insulin-like growth factor-1 mutation. J Clin Endocrinol Metab 90 2855-2864.
19. S. Yakar, J.L. Liu, B. Stannard, A. Butler, D. Accili, B. Sauer and D. LeRoith (1999) Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96 7324-7329.
20. I. Ueki, G.T. Ooi, M.L. Tremblay, K.R. Hurst, L.A. Bach and Y.R. Boisclair (2000) Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system. Proc Natl Acad Sci USA 97 6868-6873.
21. S. Yakar, C.J. Rosen, W.G. Beamer, C.L. Ackert-Bicknell, Y. Wu, J.L. Liu, et al. (2002) Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110 771-781.
22. D. LeRoith, C. Bondy, S. Yakar, J.L. Liu and A. Butler (2001) The somatomedin hypothesis. Endocrinol Rev 22 53-74.
23. S.A. Kaplan and P. Cohen (2007) The somatomedin hypothesis 2007: 50 years later. J Clin Endocrinol Metab 92 4529-4535.
24. M.J. Abuzzahab, A. Schneider, A. Goddard, F. Grigorescu, C. Lautier, E. Keller, et al. (2003) IGF-1 receptor mutations resulting in intrauterine and postnatal growth failure. N Engl J Med 349 2211-2222.
25. D.W. Leung, S.A. Spencer, G. Cachianes, R.G. Hammonds, C. Collins, W.J. Henzel, et al. (1987) Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 330 537-543.
26. A.M. Lichanska and M.J. Waters (2008) New insights into growth hormone receptor function and clinical implications. Horm Res 69 138-145.
27. K. Nadeau, V. Hwa and R.G. Rosenfeld (2011) STAT5b deficiency: an unsuspected cause of growth failure, immunodeficiency and severe pulmonary disease. J Pediatr 158 701-708.
28. R.G. Rosenfeld (2006) Molecular mechanisms of IGF-1 deficiency. Horm Res 65(Suppl. 1), 15-20.
29. H.H. Domene, S.V. Bengolea, A.S. Martinez, M.G. Ropelato, P. Pennisi, P. Scaglia, et al. (2004) Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene. N Engl J Med 350 570-577.
30. V. Hwa, G. Haeusler, K.L. Pratt, B.M. Little, H. Frisch, D. Koller and R.G. Rosenfeld (2006) Total absence of functional acid labile subunit, resulting in severe insulin-like growth factor deficiency and moderate growth failure. J Clin Endocrinol Metab 91 1826-1831.
31. R.G. Rosenfeld (2007) IGF-1 therapy in growth disorders. Eur J Endocrinol 157(Suppl. 1), 557-560.
32. F. Lupu, J.D. Terwilliger, L. Kaechoong, G.V. Segre and A. Efstratiadis (2001) Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229 141-162.
33. R.G. Rosenfeld, A. Belgorosky, C. Camacho-Hubner, M.O. Savage, J.M. Wit and V. Hwa (2007) Defects in growth hormone receptor signaling. Trends Endocrinol Metab 18 134-141.
34. R.G. Rosenfeld and P. Cohen (2008) Disorders of growth hormone/insulin-like growth factor secretion and action. M.A. Sperling (Ed.) Pediatric endocrinology 3rd ed. Philadelphia, PA: Saunders 254-334.
35. http://growthgeneticsconsortium.org